Furthermore, the enrichment of a CCR7 + DC signature (mregDC) has been linked to improved survival in lung cancer, cutaneous melanoma, breast, and colorectal cancer by analyzing 4,045 human solid tumor transcriptomes from the TCGA73. Here, CCR7 is linked to colorectal cancer.